These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21301463)

  • 1. Double-contrast ultrasound: a novel surveillance tool for hepatocellular carcinoma.
    Kudo M; Hatanaka K; Kumada T; Toyoda H; Tada T
    Am J Gastroenterol; 2011 Feb; 106(2):368-70. PubMed ID: 21301463
    [No Abstract]   [Full Text] [Related]  

  • 2. Newly developed novel ultrasound technique, defect reperfusion ultrasound imaging, using sonazoid in the management of hepatocellular carcinoma.
    Kudo M; Hatanaka K; Maekawa K
    Oncology; 2010 Jul; 78 Suppl 1():40-5. PubMed ID: 20616583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of contrast-enhanced intraoperative ultrasound using Sonazoid in patients with hepatocellular carcinoma.
    Arita J; Takahashi M; Hata S; Shindoh J; Beck Y; Sugawara Y; Hasegawa K; Kokudo N
    Ann Surg; 2011 Dec; 254(6):992-9. PubMed ID: 21694582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-enhanced ultrasound techniques for guiding and assessing response to locoregional treatments for hepatocellular carcinoma.
    Andreana L; Kudo M; Hatanaka K; Chung H; Minami Y; Maekawa K; Ruggiero G
    Oncology; 2010 Jul; 78 Suppl 1():68-77. PubMed ID: 20616587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. State of the art of intraoperative ultrasound in liver surgery: current use for staging and resection guidance.
    Donadon M; Costa G; Torzilli G
    Ultraschall Med; 2014 Dec; 35(6):500-11; quiz 512-3. PubMed ID: 25474100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between contrast-enhanced intraoperative ultrasound using Sonazoid and histologic grade of resected hepatocellular carcinoma.
    Arita J; Hasegawa K; Takahashi M; Hata S; Shindoh J; Sugawara Y; Kokudo N
    AJR Am J Roentgenol; 2011 Jun; 196(6):1314-21. PubMed ID: 21606294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced ultrasonography: a recent application for the diagnosis and treatment of hepatocellular carcinoma.
    Maruyama K; Yoshikawa M; Yokosuka O
    JNMA J Nepal Med Assoc; 2008; 47(171):156-66. PubMed ID: 19079385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance and diagnostic algorithm for hepatocellular carcinoma proposed by the Liver Cancer Study Group of Japan: 2014 update.
    Kudo M; Matsui O; Izumi N; Iijima H; Kadoya M; Imai Y;
    Oncology; 2014; 87 Suppl 1():7-21. PubMed ID: 25427729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Education and Imaging. Hepatobiliary and pancreatic: spontaneous regression of hepatocellular cancer demonstrated by contrast-enhanced ultrasonography.
    Nishijima N; Marusawa H; Kita R; Osaki Y; Chiba T
    J Gastroenterol Hepatol; 2009 Jun; 24(6):1153. PubMed ID: 19638097
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of local recurrence after treatment for hepatocellular carcinoma by contrast-enhanced ultrasonography using Sonazoid: comparison with dynamic computed tomography.
    Shiozawa K; Watanabe M; Takayama R; Takahashi M; Wakui N; Iida K; Sumino Y
    J Clin Ultrasound; 2010 May; 38(4):182-9. PubMed ID: 20232404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New contrast enhanced ultrasonography agent: impact of Sonazoid on radiofrequency ablation.
    Hiraoka A; Hiasa Y; Onji M; Michitaka K
    J Gastroenterol Hepatol; 2011 Apr; 26(4):616-8. PubMed ID: 21418298
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of the therapeutic efficacy of high-intensity focused ultrasound ablation of hepatocellular carcinoma by three-dimensional sonography with a perflubutane-based contrast agent.
    Numata K; Fukuda H; Ohto M; Itou R; Nozaki A; Kondou M; Morimoto M; Karasawa E; Tanaka K
    Eur J Radiol; 2010 Aug; 75(2):e67-75. PubMed ID: 20015603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic efficacy of ultrasound in hepatocellular carcinoma diagnosis.
    Kee KM; Lu SN
    Expert Rev Gastroenterol Hepatol; 2017 Apr; 11(4):277-279. PubMed ID: 28162003
    [No Abstract]   [Full Text] [Related]  

  • 14. Ultrasound-guided treatments under low acoustic power contrast harmonic imaging for hepatocellular carcinomas undetected by B-mode ultrasonography.
    Maruyama H; Takahashi M; Ishibashi H; Okugawa H; Okabe S; Yoshikawa M; Yokosuka O
    Liver Int; 2009 May; 29(5):708-14. PubMed ID: 18803588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the imaging of hepatocellular carcinoma.
    You MW; Kim SY; Kim KW; Lee SJ; Shin YM; Kim JH; Lee MG
    Clin Mol Hepatol; 2015 Mar; 21(1):95-103. PubMed ID: 25834808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focus on treatment of large hepatocellular carcinoma.
    Abdalla EK; Vauthey JN
    Ann Surg Oncol; 2004 Dec; 11(12):1035-6. PubMed ID: 15576831
    [No Abstract]   [Full Text] [Related]  

  • 17. Usefulness of the post-vascular phase of contrast-enhanced ultrasonography with sonazoid in the evaluation of gross types of hepatocellular carcinoma.
    Hatanaka K; Chung H; Kudo M; Haji S; Minami Y; Maekawa K; Hayaishi S; Nagai T; Takita M; Kudo K; Ueda T; Tatsumi C; Kitai S; Ishikawa E; Yada N; Inoue T; Hagiwara S; Ueshima K
    Oncology; 2010 Jul; 78 Suppl 1():53-9. PubMed ID: 20616585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Guidelines for the Diagnosis and Management of Hepatocellular Carcinoma: A Comparative Review.
    Arslanoglu A; Seyal AR; Sodagari F; Sahin A; Miller FH; Salem R; Yaghmai V
    AJR Am J Roentgenol; 2016 Nov; 207(5):W88-W98. PubMed ID: 27490855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging in the diagnosis, staging, treatment, and surveillance of hepatocellular carcinoma.
    Szklaruk J; Silverman PM; Charnsangavej C
    AJR Am J Roentgenol; 2003 Feb; 180(2):441-54. PubMed ID: 12540450
    [No Abstract]   [Full Text] [Related]  

  • 20. Recent progress in radiofrequency ablation therapy for hepatocellular carcinoma.
    Ikeda K; Osaki Y; Nakanishi H; Nasu A; Kawamura Y; Jyoko K; Sano T; Sunagozaka H; Uchino K; Minami Y; Saito Y; Nagai K; Inokuchi R; Kokubu S; Kudo M
    Oncology; 2014; 87 Suppl 1():73-7. PubMed ID: 25427736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.